Ultragenyx Pharmaceutical Inc. -
Common Stock (RARE) [ST]
ARIA INTELLIGENCE BRIEF
Disclosure records for this Health Care sector security show a narrow congressional trading footprint, with a single member — Gil Cisneros — accounting for all four disclosed trades, each of which was a purchase, with no sales on record, spanning from July 2025 through March 2026. The absence of additional members means no bipartisan co-trading clusters are recorded for this ticker. In the public disclosure record, one executive-branch official has also filed two transactions in the same security, with the closest congressional and executive purchases falling 25 days apart — a sequence observable across independent filings.
Signal Congress surfaces public disclosure data. This is not investment advice and does not imply wrongdoing.
TOTAL TRADES
4
BUYS
4
SELLS
0
MEMBERS
1
unique traders
BIPARTISAN CLUSTERS
0
AVG ALPHA 60D
+7.16%
vs SPY benchmark
RARE timeline6 trades · Congress + cabinet · convergence
Positioned by disclosure date. Click any marker for its source filing.
CongressCabinetContract cut8-K13D▲ buy ▼ sell ◆ n/a ■ event
EXECUTIVE HOLDINGS
Primary-source OGE 278-T disclosures
⚡
ACTIVE CONVERGENCE SIGNAL
A cabinet official and a congressional member both purchased this ticker within 30 days. See /executive for full detail.
| OFFICIAL | AGENCY | DATE | TYPE | AMOUNT |
|---|---|---|---|---|
Brown, Samuel Boaz | Sep 2, 25 | BUY | $1K–$15K | |
Brown, Samuel Boaz | Sep 2, 25 | SELL | $1K–$15K |
4 trades
Congressional trading data from STOCK Act filings. Not investment advice.